Avibactam/ceftazidimeAcquired resistance: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1868卷 / 1期

关键词：

D O I：

10.1007/s40278-021-00557-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：100 / 100

相关论文

共 50 条

[31] OsimertinibAcquired resistance: 3 case reports
Reactions Weekly, 2017, 1661 (1) : 254 - 254
[32] AdefovirDrug resistance: 3 case reports
Reactions Weekly, 2017, 1658 (1) : 23 - 23
[33] Avibactam/ceftazidime/aztreonamLack of efficacy: 2 case reports
Reactions Weekly, 2024, 2024 (1) : 73 - 73
[34] Avibactam/ceftazidime/aztreonamTherapy ineffective: 2 case reports
Reactions Weekly, 2020, 1817 (1) : 71 - 71
[35] Avibactam/ceftazidimeAcute kidney injury: 2 case reports
Reactions Weekly, 2019, 1747 (1) : 59 - 59
[36] Avibactam/ceftazidimeGastrointestinal intolerance and neutropenia: 2 case reports
Reactions Weekly, 2020, 1797 (1) : 50 - 50
[37] Avibactam/ceftazidimeEmergence of drug resistance: case report
Reactions Weekly, 2022, 1927 (1) : 107 - 107
[38] Avibactam/ceftazidimeDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1812 (1) : 49 - 49
[39] Avibactam/ceftazidimeDevelopment drug resistance: case report
Reactions Weekly, 2022, 1899 (1) : 67 - 67
[40] Avibactam/ceftazidimeAntibacterial drug resistance: case report
Reactions Weekly, 2025, 2051 (1) : 52 - 52

← 1 2 3 4 5 →